Skip to main content
Erschienen in: Endocrine 2/2012

01.10.2012 | Original Article

Increased high-density lipoprotein cholesterol is associated with a high prevalence of pre-hypertension and hypertension in community-dwelling persons

verfasst von: Ryuichi Kawamoto, Yasuharu Tabara, Katsuhiko Kohara, Tetsuro Miki, Masanori Abe, Tomo Kusunoki

Erschienen in: Endocrine | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

The aim of this article was that high-density lipoprotein cholesterol (HDL-C) reduces blood vessel injury through its antioxidant and anti-inflammatory functions. However, the effect of HDL-C on blood pressure may be controversial. Therefore, the aim of this study was to address whether HDL-C level is associated with blood pressure, and we examined cross-sectional data from community-dwelling persons. A total of 859 men [58 ± 15 (mean ± standard deviation); 20–89 (range) (years) and 1,169 women (61 ± 13; 19–88 years)] participants not on medication for hypertension were recruited from a single community at the time of their annual health examination. We examined the relationship between cardiovascular risk factors and blood pressure status. Multiple linear regression analysis using systolic blood pressure (SBP) and diastolic blood pressure (DBP) as an objective variable showed that HDL-C was significantly and independently associated with both SBP (β = 0.138), and DBP (β = 0.144). Compared to normotensive participants with the lowest quartile of HDL-C, multivariate-adjusted odds ratio (OR) for pre-hypertension was 1.72 (1.22–2.45) for the second quartile, 1.51 (1.07–2.15) for the third quartile, and 1.52 (1.04–2.22) for the highest quartile. Moreover, compared with normotensive participants with the lowest quartile, the multivariate-adjusted ORs for hypertension were 2.37 (1.63–3.45), 2.24 (1.54–3.28), 3.15 (2.10–4.74), respectively. There were no interactions between the two groups stratified by gender, age, BMI, drinking status, TG, FPG, and medication. Therefore, we concluded that HDL-C levels were positively associated with blood pressure in Japanese dwelling-community persons.
Literatur
1.
Zurück zum Zitat P.P. Toth, The “good cholesterol” high-density lipoprotein. Circulation 111, e89–e91 (2005)PubMedCrossRef P.P. Toth, The “good cholesterol” high-density lipoprotein. Circulation 111, e89–e91 (2005)PubMedCrossRef
2.
Zurück zum Zitat S.E. Nissen, J.C. Tardif, S.J. Nicholls, J.H. Revkin, C.L. Shear, W.T. Duggan, W. Ruzyllo, W.B. Bachinsky, G.P. Lasala, E.M. Tuzcu, ILLUSTRATE investigators: effect of torcetrapib on the progression of coronary atherosclerosis. N. Engl. J. Med. 356, 1304–1316 (2007)PubMedCrossRef S.E. Nissen, J.C. Tardif, S.J. Nicholls, J.H. Revkin, C.L. Shear, W.T. Duggan, W. Ruzyllo, W.B. Bachinsky, G.P. Lasala, E.M. Tuzcu, ILLUSTRATE investigators: effect of torcetrapib on the progression of coronary atherosclerosis. N. Engl. J. Med. 356, 1304–1316 (2007)PubMedCrossRef
3.
Zurück zum Zitat K. Shiwaku, A. Nogi, K. Kitajima, E. Anuurad, B. Enkhmaa, M. Yamasaki, J.M. Kim, I.S. Kim, S.K. Lee, T. Oyunsuren, Y. Yamane, Prevalence of the metabolic syndrome using the modified ATP III definitions for workers in Japan, Korea and Mongolia. J. Occup. Health 47, 126–135 (2005)PubMedCrossRef K. Shiwaku, A. Nogi, K. Kitajima, E. Anuurad, B. Enkhmaa, M. Yamasaki, J.M. Kim, I.S. Kim, S.K. Lee, T. Oyunsuren, Y. Yamane, Prevalence of the metabolic syndrome using the modified ATP III definitions for workers in Japan, Korea and Mongolia. J. Occup. Health 47, 126–135 (2005)PubMedCrossRef
4.
5.
Zurück zum Zitat N.M. Kaplan, The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch. Intern. Med. 149, 1514–1520 (1989)PubMedCrossRef N.M. Kaplan, The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch. Intern. Med. 149, 1514–1520 (1989)PubMedCrossRef
6.
Zurück zum Zitat R.A. DeFronzo, E. Ferrannini, Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14, 173–194 (1991)PubMedCrossRef R.A. DeFronzo, E. Ferrannini, Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14, 173–194 (1991)PubMedCrossRef
7.
Zurück zum Zitat R. Kawamoto, K. Kohara, Y. Tabara, M. Abe, T. Kusunoki, T. Miki, Insulin resistance and prevalence of pre-hypertension and hypertension among community-dwelling persons. J. Atheroscler. Thromb. 17, 148–155 (2010)PubMedCrossRef R. Kawamoto, K. Kohara, Y. Tabara, M. Abe, T. Kusunoki, T. Miki, Insulin resistance and prevalence of pre-hypertension and hypertension among community-dwelling persons. J. Atheroscler. Thromb. 17, 148–155 (2010)PubMedCrossRef
8.
Zurück zum Zitat P.S. Tsai, T.L. Ke, C.J. Huang, J.C. Tsai, P.L. Chen, S.Y. Wang, Y.K. Shyu, Prevalence and determinants of pre-hypertension status in the Taiwanese general population. J. Hypertens. 23, 1355–1360 (2005)PubMedCrossRef P.S. Tsai, T.L. Ke, C.J. Huang, J.C. Tsai, P.L. Chen, S.Y. Wang, Y.K. Shyu, Prevalence and determinants of pre-hypertension status in the Taiwanese general population. J. Hypertens. 23, 1355–1360 (2005)PubMedCrossRef
9.
Zurück zum Zitat R. Kawamoto, K. Kohara, Y. Tabara, M. Abe, T. Kusunoki, T. Miki, Insulin resistance and prevalence of pre-hypertension and hypertension among community-dwelling persons. J. Atheroscler. Thromb. 17, 148–155 (2010)PubMedCrossRef R. Kawamoto, K. Kohara, Y. Tabara, M. Abe, T. Kusunoki, T. Miki, Insulin resistance and prevalence of pre-hypertension and hypertension among community-dwelling persons. J. Atheroscler. Thromb. 17, 148–155 (2010)PubMedCrossRef
10.
Zurück zum Zitat P.J. Chowienczyk, G.F. Watts, J.R. Cockcroft, J.M. Ritter, Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 340, 1430–1432 (1992)PubMedCrossRef P.J. Chowienczyk, G.F. Watts, J.R. Cockcroft, J.M. Ritter, Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 340, 1430–1432 (1992)PubMedCrossRef
11.
Zurück zum Zitat P.R. Casino, C.M. Kilcoyne, A.A. Quyyumi, J.M. Hoeg, J.A. Panza, The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 88, 2541–2547 (1993)PubMedCrossRef P.R. Casino, C.M. Kilcoyne, A.A. Quyyumi, J.M. Hoeg, J.A. Panza, The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 88, 2541–2547 (1993)PubMedCrossRef
12.
Zurück zum Zitat E. Oda, R. Kawai, High-density lipoprotein cholesterol is positively associated with hypertension in apparently healthy Japanese men and women. Br. J. Biomed. Sci. 68, 29–33 (2011)PubMed E. Oda, R. Kawai, High-density lipoprotein cholesterol is positively associated with hypertension in apparently healthy Japanese men and women. Br. J. Biomed. Sci. 68, 29–33 (2011)PubMed
13.
Zurück zum Zitat R. Kawamoto, Y. Tabara, K. Kohara, T. Miki, T. Kusunoki, S. Takayama, M. Abe,T. Katho, N. Ohtsuka, Usefulness of combining serum uric acid and high-sensitivity C-reactive protein for risk stratification of patients with metabolic syndrome in community-dwelling women. Endocrine 41, in press (2012) R. Kawamoto, Y. Tabara, K. Kohara, T. Miki, T. Kusunoki, S. Takayama, M. Abe,T. Katho, N. Ohtsuka, Usefulness of combining serum uric acid and high-sensitivity C-reactive protein for risk stratification of patients with metabolic syndrome in community-dwelling women. Endocrine 41, in press (2012)
14.
Zurück zum Zitat A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr, D.W. Jones, B.J. Materson, S. Oparil, J.T. Wright Jr, E.J. Roccella, Joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. National heart, lung, and blood institute; national high blood pressure education program coordinating committee: the seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42, 1206–1252 (2003)PubMedCrossRef A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr, D.W. Jones, B.J. Materson, S. Oparil, J.T. Wright Jr, E.J. Roccella, Joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. National heart, lung, and blood institute; national high blood pressure education program coordinating committee: the seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42, 1206–1252 (2003)PubMedCrossRef
15.
Zurück zum Zitat W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502 (1972)PubMed W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502 (1972)PubMed
16.
Zurück zum Zitat E. Imai, M. Horio, T. Watanabe, K. Iseki, K. Yamagata, S. Hara, N. Ura, Y. Kiyohara, T. Moriyama, Y. Ando, S. Fujimoto, T. Konta, H. Yokoyama, H. Makino, A. Hishida, S. Matsuo, Prevalence of chronic kidney disease in the Japanese general population. Clin. Exp. Nephrol. 13, 621–630 (2009)PubMedCrossRef E. Imai, M. Horio, T. Watanabe, K. Iseki, K. Yamagata, S. Hara, N. Ura, Y. Kiyohara, T. Moriyama, Y. Ando, S. Fujimoto, T. Konta, H. Yokoyama, H. Makino, A. Hishida, S. Matsuo, Prevalence of chronic kidney disease in the Japanese general population. Clin. Exp. Nephrol. 13, 621–630 (2009)PubMedCrossRef
17.
Zurück zum Zitat Emerging Risk Factors Collaboration, E. Di Angelantonio, N. Sarwar, P. Perry, S. Kaptoge, K.K. Ray, A. Thompson, A.M. Wood, S. Lewington, N. Sattar, C.J. Packard, R. Collins, S.G. Thompson, J. Danesh, Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302, 1993–2000 (2009)PubMedCrossRef Emerging Risk Factors Collaboration, E. Di Angelantonio, N. Sarwar, P. Perry, S. Kaptoge, K.K. Ray, A. Thompson, A.M. Wood, S. Lewington, N. Sattar, C.J. Packard, R. Collins, S.G. Thompson, J. Danesh, Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302, 1993–2000 (2009)PubMedCrossRef
18.
Zurück zum Zitat R.O. Halperin, H.D. Sesso, J. Ma, J.E. Buring, M.J. Stampfer, J.M. Gaziano, Dyslipidemia and the risk of incident hypertension in men. Hypertension 47, 45–50 (2006)PubMedCrossRef R.O. Halperin, H.D. Sesso, J. Ma, J.E. Buring, M.J. Stampfer, J.M. Gaziano, Dyslipidemia and the risk of incident hypertension in men. Hypertension 47, 45–50 (2006)PubMedCrossRef
19.
Zurück zum Zitat H.D. Sesso, J.E. Buring, M.J. Chown, P.M. Ridker, J.M. Gaziano, A prospective study of plasma lipid levels and hypertension in women. Arch. Intern. Med. 165, 2420–2427 (2005)PubMedCrossRef H.D. Sesso, J.E. Buring, M.J. Chown, P.M. Ridker, J.M. Gaziano, A prospective study of plasma lipid levels and hypertension in women. Arch. Intern. Med. 165, 2420–2427 (2005)PubMedCrossRef
20.
Zurück zum Zitat N.P. Paynter, H.D. Sesso, D. Conen, J.D. Otvos, S. Mora, Lipoprotein subclass abnormalities and incident hypertension in initially healthy women. Clin. Chem. 57, 1178–1187 (2011)PubMedCrossRef N.P. Paynter, H.D. Sesso, D. Conen, J.D. Otvos, S. Mora, Lipoprotein subclass abnormalities and incident hypertension in initially healthy women. Clin. Chem. 57, 1178–1187 (2011)PubMedCrossRef
21.
Zurück zum Zitat H. Becher, The concept of residual confounding in regression models and some applications. Stat. Med. 11, 1747–1758 (1992)PubMedCrossRef H. Becher, The concept of residual confounding in regression models and some applications. Stat. Med. 11, 1747–1758 (1992)PubMedCrossRef
22.
Zurück zum Zitat M. Vergeer, A.G. Holleboom, J.J.P. Kastelein, J.A. Kuivenhoven, The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis? Lipid Res. 51, 2058–2073 (2010)CrossRef M. Vergeer, A.G. Holleboom, J.J.P. Kastelein, J.A. Kuivenhoven, The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis? Lipid Res. 51, 2058–2073 (2010)CrossRef
24.
Zurück zum Zitat H. Drexel, F.W. Amann, K. Rentsch, C. Neuenschwander, A. Luethy, S.I. Khan, F. Follath, Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease. Am. J. Cardiol. 70, 436–440 (1992)PubMedCrossRef H. Drexel, F.W. Amann, K. Rentsch, C. Neuenschwander, A. Luethy, S.I. Khan, F. Follath, Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease. Am. J. Cardiol. 70, 436–440 (1992)PubMedCrossRef
25.
Zurück zum Zitat M. Navab, S.Y. Hama, G.P. Hough, G. Subbanagounder, S.T. Reddy, A.M. Fogelman, A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. J. Lipid Res. 42, 1308–1317 (2001)PubMed M. Navab, S.Y. Hama, G.P. Hough, G. Subbanagounder, S.T. Reddy, A.M. Fogelman, A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. J. Lipid Res. 42, 1308–1317 (2001)PubMed
26.
Zurück zum Zitat W.S. Davidson, R.A. Silva, S. Chantepie, W.R. Lagor, M.J. Chapman, A. Kontush, Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function. Arterioscler. Thromb. Vasc. Biol. 29, 870–876 (2009)PubMedCrossRef W.S. Davidson, R.A. Silva, S. Chantepie, W.R. Lagor, M.J. Chapman, A. Kontush, Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function. Arterioscler. Thromb. Vasc. Biol. 29, 870–876 (2009)PubMedCrossRef
27.
Zurück zum Zitat B.J. Ansell, G.C. Fonarow, A.M. Fogelman, High-density lipoprotein: is it always atheroprotective? Curr. Atheroscler. Rep. 8, 405–411 (2006)PubMedCrossRef B.J. Ansell, G.C. Fonarow, A.M. Fogelman, High-density lipoprotein: is it always atheroprotective? Curr. Atheroscler. Rep. 8, 405–411 (2006)PubMedCrossRef
28.
Zurück zum Zitat M. Navab, G.M. Ananthramaiah, S.T. Reddy, B.J. Van Lenten, B.J. Ansell, S. Hama, G. Hough, E. Bachini, V.R. Grijalva, A.C. Wagner, Z. Shaposhnik, A.M. Fogelman, The double jeopardy of HDL. Ann. Med. 37, 173–178 (2005)PubMedCrossRef M. Navab, G.M. Ananthramaiah, S.T. Reddy, B.J. Van Lenten, B.J. Ansell, S. Hama, G. Hough, E. Bachini, V.R. Grijalva, A.C. Wagner, Z. Shaposhnik, A.M. Fogelman, The double jeopardy of HDL. Ann. Med. 37, 173–178 (2005)PubMedCrossRef
29.
Zurück zum Zitat E.R. De Oliveira E Silva, D. Foster, M. McGee Harper, C.E. Seidman, J.D. Smith, J.L. Breslow, E.A. Brinton, Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation 102, 2347–2352 (2000)PubMedCrossRef E.R. De Oliveira E Silva, D. Foster, M. McGee Harper, C.E. Seidman, J.D. Smith, J.L. Breslow, E.A. Brinton, Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation 102, 2347–2352 (2000)PubMedCrossRef
30.
Zurück zum Zitat F.D. Fuchs, L.E. Chambless, P.K. Whelton, F.J. Nieto, G. Heiss, Alcohol consumption and the incidence of hypertension: the atherosclerosis risk in communities study. Hypertension 37, 1242–1250 (2001)PubMedCrossRef F.D. Fuchs, L.E. Chambless, P.K. Whelton, F.J. Nieto, G. Heiss, Alcohol consumption and the incidence of hypertension: the atherosclerosis risk in communities study. Hypertension 37, 1242–1250 (2001)PubMedCrossRef
31.
Zurück zum Zitat H.D. Sesso, N.R. Cook, J.E. Buring, J.E. Manson, J.M. Gaziano, Alcohol consumption and the risk of hypertension in women and men. Hypertension 51, 1080–1087 (2008)PubMedCrossRef H.D. Sesso, N.R. Cook, J.E. Buring, J.E. Manson, J.M. Gaziano, Alcohol consumption and the risk of hypertension in women and men. Hypertension 51, 1080–1087 (2008)PubMedCrossRef
Metadaten
Titel
Increased high-density lipoprotein cholesterol is associated with a high prevalence of pre-hypertension and hypertension in community-dwelling persons
verfasst von
Ryuichi Kawamoto
Yasuharu Tabara
Katsuhiko Kohara
Tetsuro Miki
Masanori Abe
Tomo Kusunoki
Publikationsdatum
01.10.2012
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2012
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-012-9625-z

Weitere Artikel der Ausgabe 2/2012

Endocrine 2/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.